mirtazapine has been researched along with piperidines in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Smith, DF | 1 |
Robertson, VB; Wilson, MS | 1 |
Bhagwagar, Z; Cowen, PJ; Cunningham, VJ; Grasby, PM; Hinz, R | 1 |
Benyamina, A; Blecha, L; Lecacheux, M; Lukasiewcz, M; Reynaud, M | 1 |
Bhagwagar, Z; Cowen, PJ; Cunningham, VJ; Grasby, PM; Hinz, R; Meyer, PT | 1 |
Berdel, WE; Grauer, OM; Kerkhoff, A; Keßler, T; Lenz, G; Lutz, M; Rebber, E; Schulze, AB; Wiebe, S; Zoubi, T | 1 |
1 review(s) available for mirtazapine and piperidines
Article | Year |
---|---|
Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence.
Topics: Behavior Therapy; Buspirone; Cannabinoids; Cognitive Behavioral Therapy; Combined Modality Therapy; Dronabinol; Humans; Marijuana Abuse; Mianserin; Mirtazapine; Motivation; Piperidines; Psychotherapy; Psychotropic Drugs; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Substance Withdrawal Syndrome | 2008 |
5 other study(ies) available for mirtazapine and piperidines
Article | Year |
---|---|
The stereoselectivity of serotonin uptake in brain tissue and blood platelets: the topography of the serotonin uptake area.
Topics: Alanine; Amphetamine; Aniline Compounds; Animals; Antidepressive Agents; Blood Platelets; Brain; Fluoxetine; Humans; Male; Methadone; Mianserin; Mirtazapine; Morpholines; Naphthalenes; Nefopam; Nomifensine; Paroxetine; Piperidines; Rabbits; Serotonin; Stereoisomerism; Tranylcypromine; Viloxazine; Zimeldine | 1986 |
Neurotensin receptor agonists and antagonists for schizophrenia.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Data Interpretation, Statistical; Humans; Mianserin; Mirtazapine; Neurotensin; Peptide Fragments; Piperidines; Pyrazoles; Quinolines; Receptors, Neurotensin; Research Design; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2005 |
Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.
Topics: Adult; Antidepressive Agents; Brain; Brain Chemistry; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Female; Fluorobenzenes; Humans; Image Processing, Computer-Assisted; Kinetics; Magnetic Resonance Imaging; Male; Mianserin; Middle Aged; Mirtazapine; Models, Neurological; Models, Statistical; Piperidines; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, Serotonin, 5-HT2A; Reproducibility of Results; Serotonin Antagonists; Spectrophotometry, Ultraviolet | 2007 |
Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.
Topics: Adult; Brain; Brain Mapping; Carbon Radioisotopes; Female; Fluorobenzenes; Humans; Kinetics; Linear Models; Male; Mianserin; Middle Aged; Mirtazapine; Models, Neurological; Piperidines; Positron-Emission Tomography; Receptor, Serotonin, 5-HT2A; Serotonin Agents; Signal Processing, Computer-Assisted | 2010 |
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia.
Topics: Adenine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Disease Progression; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukoencephalopathy, Progressive Multifocal; Male; Mefloquine; Mianserin; Mirtazapine; Multimodal Imaging; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines | 2017 |